Approvals/CIMA-AEMPS/SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b36879b089c2b866
Drug Cima Aemps Name: SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 88915
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-06-19
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg/0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

SOLIFENACINA SUCCINATO

6 mg

TAMSULOSINA HIDROCLORURO

0,4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 19, 2023

Approval ID

b36879b089c2b866

Type

Standard